In-Vitro Diagnostics Market Size Worth USD 118.44 Billion in 2028.

1
In-Vitro Diagnostics Market Size Worth USD 118.44
Billion in 2028.
www.emergenresearch.com
Increasing investment in RD in molecular
diagnostics, new product development, and rising
prevalence of targeted diseases are some key
factors driving market revenue growth.
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
The global In-Vitro Diagnostics (IVD) market size
is expected to reach USD 118.44 Billion at a
steady revenue CAGR of 4.4 in 2028, according to
latest analysis by Emergen Research. In-vitro
diagnostics market revenue growth is due to
increased investment in research development in
genomics and proteomics, and rising prevalence of
targeted diseases. Rapid increase in geriatric
population globally, rising prevalence of
sedentary lifestyle-related diseases and
conditions, and rise in infectious diseases rates
are other factors driving revenue growth of the
global market. Increase in prevalence of targeted
diseases such as gastrointestinal diseases,
diabetes, cardiac disorders, and cancer, is also
contributing positively to global in-vitro
diagnostic market revenue growth. According to
International Diabetes Federation (IDF), 463
million people suffer from diabetes globally.
Just over 1 in 10 Americans have diabetes and
continuous increase in this number is driving
demand for IVD products for rapid testing. Rising
need for surgical procedures is expected to fuel
market growth. Increased awareness about
personalized medicine and adoption of
point-of-care testing is also contributing to
in-vitro diagnostics market growth. However,
stringent regulatory framework and unfavorable
reimbursement policy could negatively impact
market growth. Moreover, shortage of skilled
professionals to perform diagnostic tests
effectively and lack of training programs are
hampering adoption of in-vitro diagnostics
products. .
www.emergenresearch.com
6
Market Summary
Some Key Highlights from the Report In July 2021,
Ortho Clinical Diagnostics launched Interleukin-6
(IL-6) reagent pack, which is the latest addition
to Ortho's critical care blood testing menu.
Ortho is one of the worlds leading in-vitro
diagnostic companies and is available in the EU
countries and several LATAM and APAC countries.
The test is used to detect and evaluate
inflammatory diseases, including auto-immune
disorders, sepsis, and severe respiratory
infections from COVID-19. Reagent segment
accounted for largest revenue share in 2020.
These kits and reagents are first-line testing
devices for at-home consumer-friendly glucose
monitoring and pregnancy tests and an alternative
to more complex automated laboratory-based
systems. Increase in production of rapid,
sensitive devices, which offer more accurate
results is also driving revenue growth of this
segment. Infectious diseases segment revenue is
expected to expand at the fastest rate during the
forecast period due to increasing rates of
mortality and morbidity. Increased research
activities and high level of funding from
governments worldwide to develop solutions for
prevention and treatment of infectious disease is
propelling revenue growth of this segment. North
America accounted for largest revenue share in
2020. Increasing investment in healthcare sector
each year to improve basic healthcare services
and modernize infrastructure is supporting market
revenue growth. High demand for IVD products from
the U.S. due to rising awareness for IVD products
is contributing to growth of the market.
Continuous product innovation and demand for
rapid testing in the country is driving market
revenue growth. Some major companies operating in
the market include Siemens Healthineers, Roche
Diagnostics, Danaher Corporation, bioMérieux,
Abbott Laboratories, DiaSorin, Thermo Fisher
Scientific, Inc., Ortho Clinical Diagnostics,
QIAGEN, and Sysmex Corporation.. Request Free
Sample Copy_at_ https//www.emergenresearch.com/reque
st-sample/70
www.emergenresearch.com
7
Market Summary
Emergen Research has segmented the global
in-vitro diagnostics market on the basis of
product, devices, application, technique,
end-use, and region Product Outlook (Revenue,
USD Billion 20182028) Reagents
Kits Instruments Fully Automated
Instruments Semi-Automated Instruments Data
Management Software Services Devices Outlook
(Revenue, USD Billion 20182028) Reusable IVD
Devices Disposable IVD Devices Application
Outlook (Revenue, USD Billion 20182028) Cancer I
nfectious Diseases Diabetes Gastrointestinal
Disease Autoimmune Diseases Cardiac Disease Read
More_at_ https//www.emergenresearch.com/industry-rep
ort/in-vitro-diagnostics-market
8
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2027
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
9
Regional Share Dynamics
www.emergenresearch.com
10
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
www.emergenresearch.com
11
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 [phone]